The neuroprotective efficacy of the DPP-4 inhibitor linagliptin against stroke is not mediated by GLP-1 receptor activation

被引：0
|
作者：
Darsalia, V. [1 ]
Larsson, M. [1 ]
Nathanson, D. [1 ]
Drucker, D. J. [2 ,3 ]
Nystrom, T. [1 ]
Klein, T. [4 ]
Patrone, C. [1 ]
机构：
[1] Karolinska Inst, Dept Clin Sci & Educ, Sodersjukhuset, Internal Med, Stockholm, Sweden
[2] Univ Toronto, Mt Sinai Hosp, Dept Med, Toronto, ON M5S 1A1, Canada
[3] Univ Toronto, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5S 1A1, Canada
[4] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
来源：
DIABETOLOGIA | 2015年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
71
引用
收藏
页码：S35 / S35
页数：1
相关论文
共 50 条
  • [21] GLP-1 Receptor Independent Effects of DPP-4 Inhibition in Mice with 5/6 Nephrectomy
    Hasan, Ahmed Abdallah
    Reichetzeder, Christoph
    Guo, Jingli
    Von Websky, Karoline
    Tsuprykov, Oleg
    Klein, Thomas
    Hocher, Berthold
    DIABETES, 2016, 65 : A132 - A132
  • [22] Mortality Differences SGLT-2, DPP-4 Inhibitors and GLP-1 Receptor Agonists
    不详
    DIABETES STOFFWECHSEL UND HERZ, 2018, 27 (03): : 173 - 173
  • [23] Comparative pharmacology of the Dipeptidyl Peptidase-4 (DPP-4) metabolites of GLP-1 and the GLP-1 analogue, liraglutide
    Tomaselli, K.
    Herich, J.
    Xu, K.
    Yuskin, D.
    Collins, L.
    Crogan-Grundy, C.
    Wang, Y.
    Brunel, F.
    Lopez, J. Alfaro
    Sharma, A.
    Hanley, M.
    Ghosh, S.
    DIABETOLOGIA, 2009, 52 : S305 - S305
  • [24] Sulfonylurea Prescribing Patterns After the Introduction of DPP-4 Inhibitors and GLP-1 Receptor Agonists
    Payk, Stephanie L.
    Drew, Richard H.
    Smith, Jennifer D.
    Jiroutek, Michael R.
    Holland, Melissa A.
    CLINICAL THERAPEUTICS, 2015, 37 (07) : 1477 - 1482
  • [25] Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice
    Rieg, Timo
    Gerasimova, Maria
    Murray, Fiona
    Masuda, Takahiro
    Tang, Tong
    Rose, Michael
    Drucker, Daniel J.
    Vallon, Volker
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2012, 303 (07) : F963 - F971
  • [26] GLP-1 receptor independent effects of DPP-4 inhibition in mice with 5/6 nephrectomy
    Hocher, B.
    Hasan, A.
    Reichetzeder, C.
    Guo, J.
    von Websky, K.
    Tsuprykov, O.
    Klein, T.
    DIABETOLOGIA, 2016, 59 : S509 - S510
  • [27] Role of GLP-1 and DPP-4 in diabetic nephropathy and cardiovascular disease
    Panchapakesan, Usha
    Mather, Amanda
    Pollock, Carol
    CLINICAL SCIENCE, 2013, 124 (1-2) : 17 - 26
  • [28] DPP-4 Inhibitor Linagliptin is Neuroprotective in Hyperglycemic Mice with Stroke via the AKT/mTOR Pathway and Anti-apoptotic Effects
    Gang Zhang
    Samuel Kim
    Xiaohuan Gu
    Shan Ping Yu
    Ling Wei
    NeuroscienceBulletin, 2020, 36 (04) : 407 - 418
  • [29] DPP-4 Inhibitor Linagliptin is Neuroprotective in Hyperglycemic Mice with Stroke via the AKT/mTOR Pathway and Anti-apoptotic Effects
    Gang Zhang
    Samuel Kim
    Xiaohuan Gu
    Shan Ping Yu
    Ling Wei
    Neuroscience Bulletin, 2020, 36 : 407 - 418
  • [30] DPP-4 Inhibitor Linagliptin is Neuroprotective in Hyperglycemic Mice with Stroke via the AKT/mTOR Pathway and Anti-apoptotic Effects
    Zhang, Gang
    Kim, Samuel
    Gu, Xiaohuan
    Yu, Shan Ping
    Wei, Ling
    NEUROSCIENCE BULLETIN, 2020, 36 (04) : 407 - 418
12345